title: Impact of sex steroid ablation on viral, tumour and vaccine responses in aged mice.
abstract: Recent evidence suggests that the decline in resistance to viral infections with age occurs predominantly as a result of a gradual loss of naïve antigen-specific T cells. As such, restoration of the naïve T cell repertoire to levels seen in young healthy adults may improve defence against infection in the aged. We have previously shown that sex steroid ablation (SSA) rejuvenates the ageing thymus and increases thymic export of naïve T cells, but it remains unclear whether T cell responses are improved. Using mouse models of clinically relevant diseases, we now demonstrate that SSA increases the number of naïve T cells able to respond to antigen, thereby enhancing effector responses in aged mice. Specifically, aged mice exhibit a delay in clearing influenza A virus, which correlates with diminished specific cytotoxic activity. This is due to a decreased magnitude of response and not an intrinsic defect in effector T cell function. Upon SSA, aged mice exhibit increased T cell responsiveness that restores efficient viral clearance. We further demonstrate that SSA decreases the incidence of an inducible tumour in aged mice and can potentially increase their responsiveness to a low-dose human papillomavirus vaccine in clearing pre-formed tumours. As thymectomy abrogates the increase in T cell numbers and responsiveness following SSA, we propose that the T cell effects of SSA are dependent on thymic reactivation and subsequent replenishment of the peripheral T cell pool with newly emigrated naïve T cells. These findings have important implications for strategies to improve protection from infection and responsiveness to vaccination in the aged.
authors.affiliation: Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, Victoria, Australia. tracy.heng@monash.edu
authors.forename: Tracy S P
authors.initials: TS
authors.lastname: Heng
authors.forename: Jessica J
authors.initials: JJ
authors.lastname: Reiseger
authors.forename: Anne L
authors.initials: AL
authors.lastname: Fletcher
authors.forename: Graham R
authors.initials: GR
authors.lastname: Leggatt
authors.forename: Olivia J
authors.initials: OJ
authors.lastname: White
authors.forename: Katerina
authors.initials: K
authors.lastname: Vlahos
authors.forename: Ian H
authors.initials: IH
authors.lastname: Frazer
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Turner
authors.forename: Richard L
authors.initials: RL
authors.lastname: Boyd
mesh_terms: D000375:Aging / Q000276:immunology*; D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology*; D002369:Castration; D003602:Cytotoxicity, Immunologic; D004306:Dose-Response Relationship, Immunologic; D012739:Gonadal Steroid Hormones / Q000172:deficiency* / Q000378:metabolism; D006801:Humans; D007156:Immunologic Memory / Q000276:immunology; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology*; D018655:Lymphocyte Count; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009369:Neoplasms / Q000276:immunology*; D012038:Regeneration; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology / Q000473:pathology; D014611:Vaccination
chemical_list: D019496:Cancer Vaccines; D012739:Gonadal Steroid Hormones; D007252:Influenza Vaccines